PEAK6 Investments L.P. decreased its stake in NxStage Medical, Inc. (NASDAQ:NXTM) by 18.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 55,000 shares of the medical device company’s stock after selling 12,652 shares during the period. PEAK6 Investments L.P. owned 0.08% of NxStage Medical worth $1,333,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in NXTM. Public Employees Retirement Association of Colorado bought a new stake in shares of NxStage Medical in the 4th quarter worth approximately $128,000. Prudential Financial Inc. acquired a new stake in NxStage Medical in the 3rd quarter valued at approximately $202,000. Guggenheim Capital LLC increased its position in NxStage Medical by 35.5% in the 4th quarter. Guggenheim Capital LLC now owns 11,247 shares of the medical device company’s stock valued at $273,000 after acquiring an additional 2,949 shares during the period. FNY Partners Fund LP acquired a new stake in NxStage Medical in the 4th quarter valued at approximately $300,000. Finally, Aperio Group LLC increased its position in NxStage Medical by 36.8% in the 3rd quarter. Aperio Group LLC now owns 11,123 shares of the medical device company’s stock valued at $307,000 after acquiring an additional 2,990 shares during the period. 84.26% of the stock is currently owned by institutional investors and hedge funds.
In other news, SVP Winifred L. Swan sold 3,500 shares of NxStage Medical stock in a transaction on Wednesday, December 20th. The stock was sold at an average price of $25.35, for a total transaction of $88,725.00. Following the transaction, the senior vice president now directly owns 14,270 shares in the company, valued at approximately $361,744.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last quarter, insiders have sold 10,500 shares of company stock worth $261,485. 4.70% of the stock is owned by insiders.
NxStage Medical, Inc. (NASDAQ NXTM) opened at $24.06 on Wednesday. NxStage Medical, Inc. has a 1 year low of $20.45 and a 1 year high of $30.80.
NxStage Medical Company Profile
NxStage Medical, Inc is a medical technology company. The Company develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. It operates through three segments. The System One segment includes revenues from the sale and rental of the System One and PureFlow SL dialysate preparation equipment and the sale of disposable products in the home and critical care markets.
Want to see what other hedge funds are holding NXTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NxStage Medical, Inc. (NASDAQ:NXTM).
Receive News & Ratings for NxStage Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NxStage Medical and related companies with MarketBeat.com's FREE daily email newsletter.